---
title: "Skybiotech Healthcare Limited (512036) — Share Price, Financials & Analysis"
symbol: "512036"
company: "Skybiotech Healthcare Limited"
canonical: "https://tapetide.com/stocks/512036"
isin: "INE393H01016"
nse_symbol: "KAPILCOTEXLTD"
bse_code: "512036"
sector: "Textiles"
industry: "Textile Processing"
market_cap_cr: 23.1
generated_at: "2026-09-13T20:16:21.375Z"
---

# Skybiotech Healthcare Limited (512036)

Canonical page: https://tapetide.com/stocks/512036

## Company

- **NSE Symbol:** KAPILCOTEXLTD
- **BSE Code:** 512036
- **ISIN:** INE393H01016
- **Sector:** Textiles
- **Industry:** Textile Processing
- **Macro Sector:** Consumer Discretionary
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** kapilcotex.co.in

## About

Incorporated in 1983, Skybiotech Healthcare Ltd is in the business of Textile and Pharmaceuticals[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:36:08.670879Z.

- **Market Cap:** ₹23.1 Cr
- **Classification:** Microcap
- **P/E (reported):** -13.8
- **EPS (TTM):** ₹-8.68
- **EPS (reported):** ₹14.76
- **Book Value:** ₹41.75
- **Price to Book:** 2.89
- **Dividend Yield:** 0%
- **ROE:** -22.48%
- **ROCE:** -13.76%
- **Debt to Equity:** 1.05
- **Revenue (yearly):** ₹7.1 Cr
- **Net Income:** ₹-1.67 Cr
- **EBITDA:** ₹-1.47 Cr
- **52-Week High:** ₹220
- **52-Week Low:** ₹116.45
- **RSI (14):** 25.54

## Key Insights

### Weaknesses

- Stock is trading at 2.89 times its book value
- Company has low interest coverage ratio.
- Company might be capitalizing the interest cost
- Debtor days have increased from 39.5 to 57.1 days.

## Growth Rates

| Metric | QoQ | 1Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | — | -230% | -112.7% |
| ebitda margin growth | 28.57% | -21.18% | — |
| net income growth | -100% | -30.42% | — |
| revenue growth | -70% | -4.05% | — |
| roce | -32.94% | — | — |
| roe | 90% | — | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2023 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0 | 1.6 | 2.52 | 1.02 | 2.39 | 1.92 | 0.96 | 1.83 | 0.49 |
| Expenses | 0.05 | 0.04 | 1.58 | 2.83 | 2.11 | 2.31 | 2.15 | 1.41 | 2.71 | 1.02 |
| Operating Profit | -0.05 | -0.04 | 0.02 | -0.31 | -1.09 | 0.08 | -0.23 | -0.45 | -0.88 | -0.53 |
| OPM % | — | — | 1.25 | -12.3 | -106.86 | 3.35 | -11.98 | -46.88 | -48.09 | -108.16 |
| Other Income | 1.37 | 0.35 | 0.04 | 0.15 | -0.18 | 0.03 | 0.04 | 0.08 | 0.15 | 0.06 |
| Interest | 0 | 0 | 0.13 | 0.11 | -0.23 | 0.01 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0.13 | 0.14 | 0.15 | 0.12 | 0.12 | 0.12 | 0.12 | 0.11 |
| Profit before tax | 1.32 | 0.31 | -0.2 | -0.41 | -1.19 | -0.02 | -0.31 | -0.49 | -0.85 | -0.58 |
| Tax % | 18.94 | 19.35 | 30 | -4.88 | -8.4 | 0 | 0 | 0 | -64.71 | 0 |
| Net Profit | 1.07 | 0.25 | -0.25 | -0.39 | -1.08 | -0.02 | -0.31 | -0.48 | -0.3 | -0.57 |
| EPS in Rs | 5.59 | 1.31 | -1.31 | -2.04 | -5.64 | -0.1 | -1.62 | -2.51 | -1.57 | -2.98 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- |
| Sales | 0 | 6.96 | 7.1 | 5.2 |
| Expenses | 0.12 | 9.21 | 8.58 | 7.29 |
| Operating Profit | -0.12 | -2.25 | -1.48 | -2.09 |
| OPM % | — | -32.33 | -20.85 | -40.19 |
| Other Income | 2 | 0.38 | 0.31 | 0.33 |
| Interest | 0 | 0.01 | 0.02 | 0 |
| Depreciation | 0 | 0.54 | 0.48 | 0.47 |
| Profit before tax | 1.88 | -2.42 | -1.67 | -2.23 |
| Tax % | 18.09 | -2.07 | -32.93 | — |
| Net Profit | 1.54 | -2.37 | -1.12 | -1.66 |
| EPS in Rs | 8.04 | -12.38 | -5.85 | -8.68 |
| Dividend Payout % | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- |
| Equity Capital | — | 1.92 | 1.92 |
| Reserves | — | 7.07 | 6.08 |
| Borrowings | — | 7.2 | 8.42 |
| Other Liabilities | — | 3.91 | 3.02 |
| Total Liabilities | — | 20.1 | 19.44 |
| Fixed Assets | — | 12.03 | 11.55 |
| CWIP | — | 0 | 0 |
| Investments | — | 2.46 | 2.24 |
| Other Assets | — | 5.61 | 5.65 |
| Total Assets | — | 20.1 | 19.44 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- |
| Cash from Operating Activity | — | -1.04 | -1.52 |
| Cash from Investing Activity | — | -9.63 | 0.02 |
| Cash from Financing Activity | — | 1.24 | 1.17 |
| Net Cash Flow | — | -9.43 | -0.33 |
| Free Cash Flow | — | -1.37 | -1.52 |
| CFO/OP | — | 46 | 103 |

### Ratios

| Item | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- |
| Debtor Days | — | 22.03 | 57.06 |
| Inventory Days | — | — | 74.68 |
| Days Payable | — | — | 79.35 |
| Cash Conversion Cycle | — | 22.03 | 52.4 |
| Working Capital Days | — | -18.88 | -1.03 |
| ROCE % | — | — | -9.32 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 57.79% | 62.71% | 62.71% | 62.71% | 62.71% | 62.71% | 63.48% | 63.48% | 63.48% | 63.48% | 63.48% | 63.48% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 35.61% | 33.86% | 33.97% | 35.02% | 34.98% | 35% | 33.96% | 33.96% | 34.88% | 34.88% | 34.65% | 34.65% |
| Others | 6.6% | 3.43% | 3.31% | 2.27% | 2.31% | 2.29% | 2.56% | 2.56% | 1.64% | 1.65% | 1.87% | 1.87% |
| No. of Shareholders | 290 | 318 | 320 | 366 | 361 | 660 | 597 | 664 | 615 | 620 | 610 | 632 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 7 / 1 / 11

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 122.46 | Sell |
| EMA (10) | 123.77 | Sell |
| SMA (20) | 129.19 | Sell |
| EMA (20) | 130.12 | Sell |
| SMA (50) | 149.63 | Sell |
| EMA (50) | 142.37 | Sell |
| SMA (100) | 148.37 | Sell |
| EMA (100) | 151.63 | Sell |
| SMA (200) | 166.17 | Sell |
| EMA (200) | 163.8 | Sell |

### Oscillators — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 25.54 | Buy |
| MACD (12,26,9) | -8.54 | Buy |
| Stochastic (14,3,3) | 0 | Buy |
| ADX (14) | 25.08 | Buy |
| Williams %R (14) | -100 | Buy |
| ATR (14) | 2.94 | Neutral |
| ROC (12) | -7.86 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 16.47 | Buy |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-05 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c5bfb8ce-f284-493e-ae2c-eb148f836d26.pdf) |
| 2026-09-05 | [Intimation Of Notice Of Shareholder Meeting-AGM Dated 30Th September 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7054fdb6-469c-49a5-ba86-a58fd61ce01b.pdf) |
| 2026-08-14 | [Board Meeting Outcome for Outcome Of Board Meeting Dated 14Th August 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8798b8e5-9172-4fcc-8efc-6bf161057294.pdf) |
| 2026-08-11 | [Board Meeting Intimation for Approval Of Un-Audited Financial Results And Limited Review Report Of The Company For The Quarter Ended On June 30 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0274c790-799b-4ad5-b731-78f83afe82ff.pdf) |
| 2026-07-19 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c66f432b-146e-4480-adab-7258efc451ab.pdf) |
| 2026-06-27 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2e4e4cc-ec37-4268-b687-ce81e5161d98.pdf) |
| 2026-05-30 | [Board Meeting Outcome for Submission Of Outcome Of Board Meeting And Submission Of Financial Results For The Quarter And Year Ended On 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19acacba-8c80-4a08-84e1-fd571ed28e90.pdf) |
| 2026-05-26 | [Board Meeting Intimation for Approval Of Audited Results For The Quarter And Year Ended On March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6764bdf5-fe03-464e-a377-cf04b6b0f8cd.pdf) |
| 2026-04-30 | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=47dc0b9e-abb8-4ab0-ad29-0f86f387fcc6.pdf) |
| 2026-04-09 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de65fcc4-476f-435d-ba7f-7dc1aae919ef.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-14 | [Un-Audited Financial Results For The Quarter Ended On 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be45418d-9fef-47a6-809b-52d49c92bf67.pdf) |
| 2026-05-30 | [Results Financials For The Year Ended On 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a85f7851-877f-48cf-9624-ed0ad315e39e.pdf) |
| 2026-02-14 | [Result- Financial Result For Quarter Ended On December 31St 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f30f9bf4-d601-42d0-a52b-7b6dbd2c2c2c.pdf) |
| 2025-11-20 | [Revised Financial Results For The Quarter Ended On 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4e3b22b-e635-4ea6-b273-17935cd9316d.pdf) |
| 2025-11-15 | [Financial Result For Quarter Ended On 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d11ad8f4-cdbb-4ca8-b7d7-0231202520cd.pdf) |
| 2025-08-14 | [Results For The Quarter Ended On 30Th June 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=075ce687-ddcf-49d9-9042-1ee76b2f05b1.pdf) |
| 2025-05-30 | [Audited Financial Results For The Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f207b93-a018-423d-82df-0b18f66d216d.pdf) |
| 2025-02-14 | [Financial Results For The Quarter Ended On 31St December 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d7fdbe6-6fa8-4f8d-8e42-82329fc45f6a.pdf) |
| 2024-11-14 | [Financial Results For The Quarter Ended On 30Th September, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7fd45537-3322-4842-8cf0-f03e93f17bf4.pdf) |
| 2024-08-14 | [Financial Results For The Quarter Ended On June 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44d7d17a-f598-4ad6-83bc-22322c67d874.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Apr - Regulation 74(5) certificate filed for quarter ended 31 March 2026; no physical shares received for demat. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Apr - Regulation 74(5) certificate filed for quarter ended 31 March 2026; no physical shares received for demat.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/de65fcc4-476f-435d-ba7f-7dc1aae919ef.pdf) |
| 30 Apr - Confirmed non-applicability of SEBI Large Corporate norms as of March 31, 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Confirmed non-applicability of SEBI Large Corporate norms as of March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/47dc0b9e-abb8-4ab0-ad29-0f86f387fcc6.pdf) |
| 30 Apr - Confirmed non-applicability of SEBI Large Corporate norms as of March 31, 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Confirmed non-applicability of SEBI Large Corporate norms as of March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/47dc0b9e-abb8-4ab0-ad29-0f86f387fcc6.pdf) |
| 16 Jan - Compliance certificate Under Reg. 74(5) of SEBI (DP) Regulation, 2018 for the quarter ended on 31st December, 2025 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 16 Jan - Compliance certificate Under Reg. 74(5) of SEBI (DP) Regulation, 2018 for the quarter ended on 31st December, 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8bf860e0-2770-488c-94aa-bfc3dd361311.pdf) |
| 14 Feb - Board approved standalone and consolidated unaudited results for quarter ended 31-Dec-2025; consolidated Q3 loss Rs48.47 lakh. | [Board Meeting Outcome for Outcome Of Board Meeting To Considered And Approved Un-Audited Financials For The Quarter Ended On 31St December, 2025 14 Feb - Board approved standalone and consolidated unaudited results for quarter ended 31-Dec-2025; consolidated Q3 loss Rs48.47 lakh.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/153d1f28-061a-4dda-9ebb-ebcbc80f79bc.pdf) |
| 11 Feb - Board meeting 14 Feb 2026 to approve unaudited Q3 results for quarter ended 31 Dec 2025. | [Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended On 31St December, 2025 11 Feb - Board meeting 14 Feb 2026 to approve unaudited Q3 results for quarter ended 31 Dec 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3b859950-fa8e-43ca-bb53-3a5788c12b88.pdf) |
| — | [Closure of Trading Window 30 Mar](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c043dda0-e85a-473a-92e0-debdf9d5c40a.pdf) |
| — | [Result- Financial Result For Quarter Ended On December 31St, 2025 14 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f30f9bf4-d601-42d0-a52b-7b6dbd2c2c2c.pdf) |
| — | [Closure of Trading Window 27 Dec 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e054ef74-238d-4e00-9367-e5a4163fcfc0.pdf) |
| — | [Standalone Statement on Impact of Audit Qualifications for the period ended March 31, 2016 30 Jul 2016](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2016/7/5C42ED36_7645_487C_9559_E2B1E1388FDE_090255.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2010 from nse](https://archives.nseindia.com/annual_reports/AR_ADVANTA_2010_2010_08042011115657.zip) |
| from nse | [Financial Year 2009 from nse](https://archives.nseindia.com/annual_reports/AR_ADVANTA_2009_2009_18082010121500.zip) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6c876919-8ef8-4b0b-99af-406a7049755f.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d55c170d-49d3-4bb4-bcbd-f7b2789ea59c.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1fd2d1a2-f760-4b96-88f9-2cbb36d6adb7.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/512036/75827512036.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/512036/71463512036_10_09_21.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/512036/66228512036.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/512036/5120360319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/512036/5120360318.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T20:16:21.375Z.